Roche Backing Liquid Biopsy's Development of New CTC Detection Method | GenomeWeb

NEW YORK (GenomeWeb News) – Uppsala BIO today announced an agreement with Roche to support a project aimed at developing a new technology for detecting circulating tumor cells.

Liquid Biopsy, a spinout of the Karolinska Institute, is developing a method based on cancer cell-specific flow properties that could provide "a much better basis for early detection, choice of treatment, and follow-up" for cancer than is currently available, Uppsala BIO said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.